Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase

Qingshen Gao, Ajay Kumar, Latika Singh, Seetha Srinivasan, David E. Wazer, Vimla Band, Vimla Band, Jon M. Huibregtse, Sylvie Beaudenon, Hamid Band

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

High-risk human papilloma viruses are known to be associated with cervical cancers. We have reported previously that the high-risk human papillomavirus (HPV) E6 oncoprotein interacts with E6TP1, a novel Rap GTPase-activating protein (RapGAP). Similar to p53 tumor suppressor protein, the high-risk HPV E6 oncoproteins target E6TP1 for degradation. The HPV16 E6-induced degradation of E6TP1 strongly correlates with its ability to immortalize human mammary epithelial cells. In this study, we used treatment with a proteasome inhibitor MG132, analysis in CHO-ts20 cells with a thermolabile ubiquitin-activating enzyme, and direct detection of ubiquitin-modified E6TP1 to demonstrate that E6TP1 is targeted for degradation by the ubiquitin-proteasome pathway both in the presence and in the absence of E6. Using deletion mutants of E6TP1, we mapped the region required and sufficient for E6 binding to COOHterminal 40 amino acid residues and showed this region to be necessary for E6-dependent degradation of E6TP1. Furthermore, the E6-binding region of E6TP1 complexes with E6AP via E6. Importantly, the purified E6AP enhanced the ubiquitination and degradation of E6TP1 in the presence of E6 in vitro. Additionally, the expression of a dominantnegative E6AP mutant (C833A) in cells inhibited the E6-induced degradation of E6TP1. These findings demonstrate that the E6-induced decrease in the levels of E6TP1 protein involves the E6AP-mediated ubiquitination followed by proteasome-dependent degradation.

Original languageEnglish (US)
Pages (from-to)3315-3321
Number of pages7
JournalCancer Research
Volume62
Issue number11
StatePublished - Jun 1 2002

Fingerprint

Ligases
Ubiquitin
Ubiquitination
Oncogene Proteins
Proteasome Endopeptidase Complex
Papillomaviridae
E6-target protein 1
Ubiquitin-Activating Enzymes
GTPase-Activating Proteins
Tumor Suppressor Protein p53
Proteasome Inhibitors
CHO Cells
Uterine Cervical Neoplasms
Breast
Epithelial Cells
Amino Acids

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Gao, Q., Kumar, A., Singh, L., Srinivasan, S., Wazer, D. E., Band, V., ... Band, H. (2002). Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Cancer Research, 62(11), 3315-3321.

Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. / Gao, Qingshen; Kumar, Ajay; Singh, Latika; Srinivasan, Seetha; Wazer, David E.; Band, Vimla; Band, Vimla; Huibregtse, Jon M.; Beaudenon, Sylvie; Band, Hamid.

In: Cancer Research, Vol. 62, No. 11, 01.06.2002, p. 3315-3321.

Research output: Contribution to journalArticle

Gao, Q, Kumar, A, Singh, L, Srinivasan, S, Wazer, DE, Band, V, Band, V, Huibregtse, JM, Beaudenon, S & Band, H 2002, 'Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase', Cancer Research, vol. 62, no. 11, pp. 3315-3321.
Gao Q, Kumar A, Singh L, Srinivasan S, Wazer DE, Band V et al. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Cancer Research. 2002 Jun 1;62(11):3315-3321.
Gao, Qingshen ; Kumar, Ajay ; Singh, Latika ; Srinivasan, Seetha ; Wazer, David E. ; Band, Vimla ; Band, Vimla ; Huibregtse, Jon M. ; Beaudenon, Sylvie ; Band, Hamid. / Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. In: Cancer Research. 2002 ; Vol. 62, No. 11. pp. 3315-3321.
@article{4c886382db604b9e9a00525ca614fbe6,
title = "Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase",
abstract = "High-risk human papilloma viruses are known to be associated with cervical cancers. We have reported previously that the high-risk human papillomavirus (HPV) E6 oncoprotein interacts with E6TP1, a novel Rap GTPase-activating protein (RapGAP). Similar to p53 tumor suppressor protein, the high-risk HPV E6 oncoproteins target E6TP1 for degradation. The HPV16 E6-induced degradation of E6TP1 strongly correlates with its ability to immortalize human mammary epithelial cells. In this study, we used treatment with a proteasome inhibitor MG132, analysis in CHO-ts20 cells with a thermolabile ubiquitin-activating enzyme, and direct detection of ubiquitin-modified E6TP1 to demonstrate that E6TP1 is targeted for degradation by the ubiquitin-proteasome pathway both in the presence and in the absence of E6. Using deletion mutants of E6TP1, we mapped the region required and sufficient for E6 binding to COOHterminal 40 amino acid residues and showed this region to be necessary for E6-dependent degradation of E6TP1. Furthermore, the E6-binding region of E6TP1 complexes with E6AP via E6. Importantly, the purified E6AP enhanced the ubiquitination and degradation of E6TP1 in the presence of E6 in vitro. Additionally, the expression of a dominantnegative E6AP mutant (C833A) in cells inhibited the E6-induced degradation of E6TP1. These findings demonstrate that the E6-induced decrease in the levels of E6TP1 protein involves the E6AP-mediated ubiquitination followed by proteasome-dependent degradation.",
author = "Qingshen Gao and Ajay Kumar and Latika Singh and Seetha Srinivasan and Wazer, {David E.} and Vimla Band and Vimla Band and Huibregtse, {Jon M.} and Sylvie Beaudenon and Hamid Band",
year = "2002",
month = "6",
day = "1",
language = "English (US)",
volume = "62",
pages = "3315--3321",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase

AU - Gao, Qingshen

AU - Kumar, Ajay

AU - Singh, Latika

AU - Srinivasan, Seetha

AU - Wazer, David E.

AU - Band, Vimla

AU - Band, Vimla

AU - Huibregtse, Jon M.

AU - Beaudenon, Sylvie

AU - Band, Hamid

PY - 2002/6/1

Y1 - 2002/6/1

N2 - High-risk human papilloma viruses are known to be associated with cervical cancers. We have reported previously that the high-risk human papillomavirus (HPV) E6 oncoprotein interacts with E6TP1, a novel Rap GTPase-activating protein (RapGAP). Similar to p53 tumor suppressor protein, the high-risk HPV E6 oncoproteins target E6TP1 for degradation. The HPV16 E6-induced degradation of E6TP1 strongly correlates with its ability to immortalize human mammary epithelial cells. In this study, we used treatment with a proteasome inhibitor MG132, analysis in CHO-ts20 cells with a thermolabile ubiquitin-activating enzyme, and direct detection of ubiquitin-modified E6TP1 to demonstrate that E6TP1 is targeted for degradation by the ubiquitin-proteasome pathway both in the presence and in the absence of E6. Using deletion mutants of E6TP1, we mapped the region required and sufficient for E6 binding to COOHterminal 40 amino acid residues and showed this region to be necessary for E6-dependent degradation of E6TP1. Furthermore, the E6-binding region of E6TP1 complexes with E6AP via E6. Importantly, the purified E6AP enhanced the ubiquitination and degradation of E6TP1 in the presence of E6 in vitro. Additionally, the expression of a dominantnegative E6AP mutant (C833A) in cells inhibited the E6-induced degradation of E6TP1. These findings demonstrate that the E6-induced decrease in the levels of E6TP1 protein involves the E6AP-mediated ubiquitination followed by proteasome-dependent degradation.

AB - High-risk human papilloma viruses are known to be associated with cervical cancers. We have reported previously that the high-risk human papillomavirus (HPV) E6 oncoprotein interacts with E6TP1, a novel Rap GTPase-activating protein (RapGAP). Similar to p53 tumor suppressor protein, the high-risk HPV E6 oncoproteins target E6TP1 for degradation. The HPV16 E6-induced degradation of E6TP1 strongly correlates with its ability to immortalize human mammary epithelial cells. In this study, we used treatment with a proteasome inhibitor MG132, analysis in CHO-ts20 cells with a thermolabile ubiquitin-activating enzyme, and direct detection of ubiquitin-modified E6TP1 to demonstrate that E6TP1 is targeted for degradation by the ubiquitin-proteasome pathway both in the presence and in the absence of E6. Using deletion mutants of E6TP1, we mapped the region required and sufficient for E6 binding to COOHterminal 40 amino acid residues and showed this region to be necessary for E6-dependent degradation of E6TP1. Furthermore, the E6-binding region of E6TP1 complexes with E6AP via E6. Importantly, the purified E6AP enhanced the ubiquitination and degradation of E6TP1 in the presence of E6 in vitro. Additionally, the expression of a dominantnegative E6AP mutant (C833A) in cells inhibited the E6-induced degradation of E6TP1. These findings demonstrate that the E6-induced decrease in the levels of E6TP1 protein involves the E6AP-mediated ubiquitination followed by proteasome-dependent degradation.

UR - http://www.scopus.com/inward/record.url?scp=0036606329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036606329&partnerID=8YFLogxK

M3 - Article

C2 - 12036950

AN - SCOPUS:0036606329

VL - 62

SP - 3315

EP - 3321

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 11

ER -